Issues seen with drugs to curb prostate cancer: FDA | Reuters

Links shared publicly online about this topic.

  • 691
    total visits

Issues seen with drugs to curb prostate cancer: FDA | Reuters

reuters.com

WASHINGTON (Reuters) - U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain

View full resource at reuters.com

Tags: Prostate, Benign Prostatic Hypertrophy Medication, Drug, Men's Health, Proscar, Avodart, News

  • Share

Most Recently Shared on November 29, 2010 at 6:23 pm By:

hrana Hisham Rana, MD

News: Issues seen with drugs (Avodart and Proscar) to curb prostate cancer: FDA http://reut.rs/fSpS8f - #health #pharma

1 year ago...

Issues seen with drugs to curb prostate cancer: FDA

health.yahoo.net — “U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain men.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on November 29, 2010 at 6:40 pm By:

JennyBizRN Jennifer Ann Grisso Active Health Library and Nurse

Issues seen with drugs to curb prostate cancer: FDA: U.S. regulatory staff have raised concerns about data for t... http://bit.ly/fh5C9B

1 year ago...

Issues seen with drugs to curb prostate cancer: FDA

health.yahoo.net — “U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain men.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on November 29, 2010 at 6:27 pm By:

nutritionbuff Jane Anderson Healthy Eating Advisor

Issues seen with drugs to curb prostate cancer: FDA http://bit.ly/hnceAQ

1 year ago...

Advertisement